======= BAZ1A ======= == Gene Information == * **Official Symbol**: BAZ1A * **Official Name**: bromodomain adjacent to zinc finger domain 1A * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=11177|11177]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NRL2|Q9NRL2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=BAZ1A&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BAZ1A|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605680|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of the ACF complex, an ATP-dependent chromatin remodeling complex, that regulates spacing of nucleosomes using ATP to generate evenly spaced nucleosomes along the chromatin. The ATPase activity of the complex is regulated by the length of flanking DNA. Also involved in facilitating the DNA replication process. BAZ1A is the accessory, non-catalytic subunit of the complex which can enhance and direct the process provided by the ATPase subunit, SMARCA5, probably through targeting pericentromeric heterochromatin in late S phase. Moves end- positioned nucleosomes to a predominantly central position. May have a role in nuclear receptor-mediated transcription repression. |Bromodomain| |WAC Acf1 DNA bd| |DDT| |PHD| |ACF complex| |CHRAC| |histone acetyltransferase activity| |histone acetylation| |internal peptidyl-lysine acetylation| |DNA-dependent DNA replication| |peptidyl-lysine acetylation| |internal protein amino acid acetylation| |protein acetylation| |chromatin remodeling| |protein acylation| |DNA replication| |peptidyl-lysine modification| |histone modification| |covalent chromatin modification| |chromatin organization| |peptidyl-amino acid modification| |chromosome organization| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp449|Arsenic trioxide 60μM R08 exp449]]|-2.56| |[[:results:exp346|CoCl2 18μM R07 exp346]]|-1.76| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|1.72| |[[:results:exp143|Phenformin 20μM R03 exp143]]|1.81| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3526 * **Expression level (log2 read counts)**: 8.01 {{:chemogenomics:nalm6 dist.png?nolink |}}